KUALA LUMPUR — March 28, 2020: Malaysia has been chosen as one of the countries to run trials on the effectiveness of a drug called remdesivir to treat Covid-19 patients.
Patients will be treated with the new drug and monitored for all side effects.
In a Facebook post, Health director-general Datuk Dr. Noor Hisham Abdullah described the decision as an unprecedented all-out coordinated push to collect robust scientific data rapidly during a pandemic.
The study, which could include many thousands of patients in dozens of countries, has been designed to be as simple as possible so that even hospitals overwhelmed by an onslaught of patients can participate.
“WHO is focusing on what it says are the four most promising therapies: an experimental antiviral compound called remdesivir; the malaria medications chloroquine and hydroxychloroquine; a combination of two HIV drugs, lopinavir and ritonavir; and that same combination plus interferon-beta, an immune system messenger that can help cripple viruses,” says the post.